{"log_id": 2576345529664815142, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0, "average": 0.995108, "min": 0.995108}, "location": {"width": 27, "top": 95, "height": 27, "left": 1091}, "words": "局"}, {"probability": {"variance": 0, "average": 0.999587, "min": 0.999574}, "location": {"width": 62, "top": 195, "height": 32, "left": 1055}, "words": "国家"}, {"probability": {"variance": 1.3e-05, "average": 0.998063, "min": 0.990053}, "location": {"width": 112, "top": 216, "height": 25, "left": 168}, "words": "【药理毒理】"}, {"probability": {"variance": 0.010407, "average": 0.957935, "min": 0.657305}, "location": {"width": 320, "top": 248, "height": 36, "left": 162}, "words": "药物分类:HMG-CoA还原酶抑制剂"}, {"probability": {"variance": 0, "average": 0.998755, "min": 0.998755}, "location": {"width": 26, "top": 241, "height": 27, "left": 1094}, "words": "药"}, {"probability": {"variance": 0.009431, "average": 0.975868, "min": 0.516168}, "location": {"width": 789, "top": 277, "height": 47, "left": 162}, "words": "氟伐他汀是一个全合成的降胆固醇药物,是羟甲基戊二酰辅酶A(HMG-CoA)还原酶抑"}, {"probability": {"variance": 0.008352, "average": 0.966634, "min": 0.635898}, "location": {"width": 783, "top": 317, "height": 46, "left": 163}, "words": "制剂,可与 hmg-coa还原酶竞争,抑制 hmg-coa转化为3-甲基-3,5-二羟戊酸,而3-甲"}, {"probability": {"variance": 0.000455, "average": 0.991465, "min": 0.895402}, "location": {"width": 778, "top": 356, "height": 46, "left": 163}, "words": "基-3,5-二羟戊酸是甾醇包括胆固醇的前体物质。本品的作用部位主要在肝脏,具有抑制"}, {"probability": {"variance": 3.4e-05, "average": 0.996159, "min": 0.970093}, "location": {"width": 780, "top": 396, "height": 45, "left": 165}, "words": "内源性胆固醇的合成,降低肝细胞内胆固醇的含量,刺激低密度脂蛋白(LDL)受体的合"}, {"probability": {"variance": 3e-06, "average": 0.99878, "min": 0.991671}, "location": {"width": 512, "top": 440, "height": 40, "left": 165}, "words": "成,提高LDL微粒的摄取,降低血浆总胆固醇浓度的作用"}, {"probability": {"variance": 0.000664, "average": 0.993763, "min": 0.836554}, "location": {"width": 791, "top": 474, "height": 44, "left": 165}, "words": "在高胆固醇血症和混合性血脂紊乱的患者中,本品可以减少总胆固醇(TC),低密度脂蛋"}, {"probability": {"variance": 0.01368, "average": 0.957556, "min": 0.472907}, "location": {"width": 776, "top": 512, "height": 46, "left": 166}, "words": "白胆固醇(LDL-C),载脂蛋白B(apo-B)和甘油三酯(TG)水平,增加高密度脂蛋白"}, {"probability": {"variance": 0.00137, "average": 0.987971, "min": 0.826217}, "location": {"width": 785, "top": 550, "height": 47, "left": 163}, "words": "胆固醇(HDL-C)水平。在使用药物2周内出现良好的治疗效果,从治疗开始4周之内出"}, {"probability": {"variance": 2.7e-05, "average": 0.997477, "min": 0.978122}, "location": {"width": 447, "top": 598, "height": 36, "left": 165}, "words": "现最大的效应,此效应在整个治疗过程中持续存在"}, {"probability": {"variance": 2.1e-05, "average": 0.996641, "min": 0.986214}, "location": {"width": 166, "top": 683, "height": 29, "left": 166}, "words": "临床前安全性资料"}, {"probability": {"variance": 1e-06, "average": 0.999159, "min": 0.997544}, "location": {"width": 83, "top": 736, "height": 25, "left": 167}, "words": "急性毒性"}, {"probability": {"variance": 0.00024, "average": 0.99091, "min": 0.934265}, "location": {"width": 579, "top": 772, "height": 40, "left": 168}, "words": "氟伐他汀在小鼠的LD50大于2g/kg,在大鼠的LD50大于0.7g/kg"}, {"probability": {"variance": 0.000213, "average": 0.992067, "min": 0.959588}, "location": {"width": 122, "top": 833, "height": 26, "left": 170}, "words": "重复剂量毒性"}, {"probability": {"variance": 5e-06, "average": 0.998413, "min": 0.990628}, "location": {"width": 787, "top": 863, "height": 50, "left": 170}, "words": "在大鼠、兔子、狗、猴子、小鼠以及仓鼠中进行了深入的毒性研究,评价氟伐他汀的安全"}, {"probability": {"variance": 0.001662, "average": 0.987404, "min": 0.804615}, "location": {"width": 788, "top": 904, "height": 45, "left": 170}, "words": "性。研究结果与HMG-CoA还原酶抑制剂的结果相同,例如啮齿类动物非腺型胃部的细胞"}, {"probability": {"variance": 4.5e-05, "average": 0.996864, "min": 0.958386}, "location": {"width": 788, "top": 940, "height": 50, "left": 170}, "words": "增生和过度角化,狗出现白内障,啮齿类动物出现肌病,大多数试验动物的肝脏出现轻微"}, {"probability": {"variance": 4.6e-05, "average": 0.997386, "min": 0.961352}, "location": {"width": 788, "top": 979, "height": 50, "left": 170}, "words": "的变化,狗、仓鼠和猴子的胆囊出现变化,大鼠甲状腺重量增加,仓鼠睾丸出现病变。尚"}, {"probability": {"variance": 0.00066, "average": 0.991724, "min": 0.851674}, "location": {"width": 699, "top": 1021, "height": 45, "left": 170}, "words": "无试验数据表明,氟伐他汀和其它此类药物对狗CNS血管及变性方面有所影响"}, {"probability": {"variance": 0, "average": 0.99971, "min": 0.999588}, "location": {"width": 65, "top": 1090, "height": 24, "left": 171}, "words": "致癌性"}, {"probability": {"variance": 0.000167, "average": 0.992989, "min": 0.938805}, "location": {"width": 789, "top": 1120, "height": 46, "left": 172}, "words": "以每天6、9、18mg/kg的给药剂量(一年后将剂量增加到每天24mg/kg)进行的一项大"}, {"probability": {"variance": 0.000583, "average": 0.99168, "min": 0.861282}, "location": {"width": 787, "top": 1157, "height": 47, "left": 172}, "words": "鼠致癌性研究,以获得最大耐受剂量。在这样的给药剂量下,相当于人治疗剂量(口服给"}, {"probability": {"variance": 0.001624, "average": 0.989013, "min": 0.737387}, "location": {"width": 784, "top": 1196, "height": 47, "left": 174}, "words": "药40mg)下血药浓度的9、13和26-35倍。在每天24mg/kg的剂量水平下,出现胃前"}, {"probability": {"variance": 0.003413, "average": 0.985704, "min": 0.620919}, "location": {"width": 786, "top": 1235, "height": 47, "left": 174}, "words": "鳞状细胞乳头状瘤和胃前癌的机率非常低。此外,对于每天按18-24mg/kg给药的雄性大"}, {"probability": {"variance": 0.000111, "average": 0.996677, "min": 0.943538}, "location": {"width": 566, "top": 1280, "height": 40, "left": 175}, "words": "鼠,甲状腺滤泡细胞瘤以及甲状腺滤泡细胞癌的发病率有所升高"}, {"probability": {"variance": 0.001262, "average": 0.989955, "min": 0.774515}, "location": {"width": 792, "top": 1324, "height": 47, "left": 174}, "words": "以每天0.3、15、30mg/kg的给药剂量进行小鼠致癌性研究,与大鼠致癌性研究一样,在"}, {"probability": {"variance": 8.7e-05, "average": 0.995984, "min": 0.955391}, "location": {"width": 790, "top": 1363, "height": 47, "left": 176}, "words": "每天30mg/kg剂量下的雄性和雌性小鼠以及在每天15mgkg的雌性小鼠,其胃前鳞状细"}, {"probability": {"variance": 0.005412, "average": 0.982109, "min": 0.543928}, "location": {"width": 752, "top": 1403, "height": 45, "left": 176}, "words": "胞乳头状瘤的机率明显增加。在这样的给药剂量下相当于人治疗剂量(口服给药40"}, {"probability": {"variance": 0.00836, "average": 0.975111, "min": 0.587848}, "location": {"width": 322, "top": 1451, "height": 35, "left": 180}, "words": "mg)下血药浓度的0.2、10和21倍"}, {"probability": {"variance": 0.051667, "average": 0.772203, "min": 0.366511}, "location": {"width": 144, "top": 1429, "height": 37, "left": 521}, "words": "产分公司"}], "language": 3}